Compare LLY & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLY | CRWD |
|---|---|---|
| Founded | 1876 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 979.6B | 174.3B |
| IPO Year | 2007 | 2019 |
| Metric | LLY | CRWD |
|---|---|---|
| Price | $1,111.65 | $672.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 48 |
| Target Price | ★ $1,218.84 | $507.00 |
| AVG Volume (30 Days) | 2.4M | ★ 3.3M |
| Earning Date | 04-30-2026 | 06-02-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | ★ 95.99 | N/A |
| EPS | ★ 8.26 | 0.11 |
| Revenue | ★ $65,179,000,000.00 | $4,812,005,000.00 |
| Revenue This Year | $27.15 | $24.85 |
| Revenue Next Year | $16.04 | $21.40 |
| P/E Ratio | ★ $134.12 | $6,187.73 |
| Revenue Growth | ★ 44.70 | 21.71 |
| 52 Week Low | $623.78 | $342.72 |
| 52 Week High | $1,182.73 | $785.66 |
| Indicator | LLY | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 56.86 | 54.73 |
| Support Level | $1,032.70 | $463.35 |
| Resistance Level | $1,165.92 | $785.66 |
| Average True Range (ATR) | 33.94 | 33.96 |
| MACD | -8.43 | -9.66 |
| Stochastic Oscillator | 31.60 | 52.86 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.